The yardsticks are under review: biology audits its own instruments

The platforms can't be compared yet

Spatial transcriptomics has a comparison problem, and a comprehensive multi-platform review in a preprint says so plainly. Sequencing-based platforms differ significantly in their transcript detection chemistry, the architecture of their capture areas, and which tissues they tolerate — enough that the authors conclude standardized terminology and operational performance metrics are prerequisites for any honest head-to-head. The field has been publishing platform A versus platform B studies on shifting definitions. The review is, in effect, demanding a shared ruler before anyone measures again. m:…5076

Bias runs the whole pipeline

The imaging side of the field gets its own audit. A prelude: the variability the review documents is not subtle — detection chemistry, capture-area architecture, and tissue compatibility all differ enough that standardization is treated as a prerequisite, not a nice-to-have. Until that exists, every cross-platform claim in the literature is, at best, provisional. m:…5076

The imaging side of the field gets its own audit. A preprint on technical biases in imaging spatial transcriptomics argues the biases are not confined to one step — they run the entire pipeline, from sample preparation through data acquisition to quantification. The authors sort them into experimental sources, like how the sample was preserved and how space was sampled, and computational ones, like z-stack registration and stitching fields of view together. Their proposed fix is a unified count modeling framework that formalizes how the biases compound and then mitigates them. The honest admission underneath: every spatial map you have seen from these platforms is a little bit a map of the instrument. What the framework does is turn an inventory of complaints into a statistical object: compounding biases formalized in one model, so the corrections propagate the way the errors did. Whether it generalizes beyond the tested cases is the open question — but it is the first honest accounting of the instrument's fingerprints. m:…5840

Novelty depends on the reference

Then comes the finding that should make every transcriptomics paper reader pause. IsoMatch, a tool for population-scale transcript integration with explicit structural criteria, shows that the choice of reference annotation significantly shapes estimates of transcript novelty — and integrating GENCODE, RefSeq, and CHESS reveals that 71.2 percent of transcript groups are specific to one annotation. Read that again: most of what counts as a transcript group exists only relative to one catalog. A claim of novel isoforms that does not say which reference was used is a claim about the catalog, not the biology. The 71.2 percent figure deserves a second look: a majority of transcript groups survive integration only as annotation-specific entities — the catalogs disagree more than they agree. For a field that routinely reports novel isoforms as discoveries, that is a credibility problem with a number on it. m:…7439

Reference-free routes

The constructive response is to need the reference less. Modulator, a preprint tool for RNA modification analysis from direct RNA sequencing, builds its fragmentforms straight from genomic alignments with no reference transcriptome, then classifies modification stoichiometry differences as transcript-, allele-, or condition-dependent. It is not just a philosophy — it scores 93 percent precision in SNP calling against the Genome in a Bottle benchmark, finds 1,253 transcript-independent modification changes in Zika-infected cells, and its m6A calls agree with GLORI maps 96 percent of the time. Modulator's Zika result shows the payoff of dropping the reference: 1,253 transcript-independent modification stoichiometry changes in infected cells — differences a reference-bound method would have sorted into the wrong bins — with 96 percent agreement with GLORI maps on m6A suggesting the freedom does not cost accuracy. The arc of the week in genomics: admit the instruments have opinions, standardize the comparisons, and where possible, cut the reference out of the loop. m:…8056